Rpharmy BlackBoxRX
  • Home
  • Therapeutic Classes
  • New and Updated Warnings
  • Safety First

Immunologic Agents and Biologics


Immune Globulins

  • AbobotulinumtoxinA
  • Anti-thymocyte Globulin (equine)
  • Anti-thymocyte Globulin (rabbit)
  • Botulinum Toxins
  • Immune Globulins (Intravenous)
  • Immune Globulins, RhoD (Intravenous)
  • IncobotulinumtoxinA
  • Lymphocyte Immune Globulin (equine)
  • OnabotulinumtoxinA
  • RimabotulinumtoxinB
  • Vaccina Immune Globulins (Intravenous)

Immunosuppressants

  • Azathioprine
  • Belatacept
  • Basiliximab
  • Cyclosporine
  • Daclizumab
  • Efalizumab
  • Everolimus
  • Sirolimus
  • Tacrolimus

Immunomodulators

  • Adalimumab
  • Etanercept*
  • Golimumab
  • Interferons(alpha)
  • Lenalidomide
  • Muromonab
  • Mycophenolate mofetil
  • Mycophenolate Sodium
  • Peginterferon
  • Sunitinib
  • Thalidomide

Antirheumatic Agents

  • Auranofin
  • Gold Sodium Thiomalate
  • Golimumab
  • Leflunomide
  • Tocilizumab

This information provides a SUMMARY of Black Box data from product labeling and does not address all warnings, precautions, or important safety data found in the product insert. It is NOT intended for use in medical decision-making. Patients and healthcare professionals should always consult the most recent product information insert available from the manufacturer, and contact a physician or care provider with any questions. This table may not be complete and may not include all boxed warnings. It is periodically updated with supplemental information from FDA safety alerts, labeling announcements, and new drug approvals.

Formweb is a product of Rpharmy, LLC. Visit our website at rpharmy.com for more information on online formularies featuring Black Box Warnings.

Copyright © 2023 Rpharmy, LLC All Rights Reserved • Terms of Use • Rpharmy Staff